Glenmark Life Sciences Limited (ALIVUS) Balance Sheet
4 Followers
Glenmark Life Sciences Limited Balance Sheet
Glenmark Life Sciences Limited's total assets for Q2 2025 were ₹36.38B, an increase of Infinity% from the previous quarter. IN:ALIVUS total liabilities were ₹6.23B for the fiscal quarter, a -126.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.